Inito builds an all-in-one at-home fertility monitor and companion app that measures four key hormones (Estrogen, LH, PdG — the urine metabolite of progesterone — and FSH) from a single test strip to predict and confirm ovulation in about 10 minutes. The product provides numerical hormone values and charts rather than simple yes/no results, helping people with irregular cycles or fertility challenges better identify fertile days and confirm ovulation.

Trusted by tens of thousands of users, Inito’s system combines a physical InSight reader, one-time-use test strips, and a mobile app that schedules tests, displays hormone trends, and notifies users when they have high or peak fertility and when ovulation is confirmed.

Inito’s mission is to empower people trying to conceive by giving them accurate, personalized hormonal data so they can make informed decisions and improve their chances of conception. The company focuses on making clinical-grade hormone information accessible at home and reducing uncertainty for users who have irregular cycles or specific fertility concerns.

Regulatory and support details: the Inito Fertility Monitor is registered in the U.S. as an FDA Class I device (exempt from premarket notification). Inito sells starter kits and refill strips, offers customer support via [email protected], and lists a U.S. headquarters in Houston, TX.